Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eva Ferreira Rodrigues"'
Autor:
Tanja Blume, Severin Filser, Etienne Herzog, Jochen Herms, Mario M. Dorostkar, Finn Peters, Derya R. Shimshek, Nils Brose, Hazal Salihoglu, Eva Ferreira Rodrigues, Ulf Neumann
Publikováno v:
Acta Neuropathologica
Acta Neuropathologica, Springer Verlag, 2018, 135 (5), pp.695-710. ⟨10.1007/s00401-017-1804-9⟩
Acta Neuropathologica (Berl)
Acta neuropathologica 135(5), 695-710 (2018). doi:10.1007/s00401-017-1804-9
Acta Neuropathologica, Springer Verlag, 2018, 135 (5), pp.695-710. ⟨10.1007/s00401-017-1804-9⟩
Acta Neuropathologica (Berl)
Acta neuropathologica 135(5), 695-710 (2018). doi:10.1007/s00401-017-1804-9
BACE1 is the rate-limiting protease in the production of synaptotoxic β-amyloid (Aβ) species and hence one of the prime drug targets for potential therapy of Alzheimer’s disease (AD). However, so far pharmacological BACE1 inhibition failed to res
Autor:
Jochen Herms, Armin Giese, Lidia Blazquez-Llorca, Finn Peters, Sonja Blumenstock, Eva Ferreira Rodrigues, Felix Schmidt
Publikováno v:
EMBO molecular medicine 9(5), 716-731 (2017). doi:10.15252/emmm.201607305
EMBO Molecular Medicine
EMBO Molecular Medicine
Although misfolded and aggregated α‐synuclein (α‐syn) is recognized in the disease progression of synucleinopathies, its role in the impairment of cortical circuitries and synaptic plasticity remains incompletely understood. We investigated how
Autor:
Eva Ferreira Rodrigues, Jochen Herms, Saak V. Ovsepian, Susana Valero Freitag, Lidia Blazquez-Llorca
Publikováno v:
Cerebral cortex 27(10), cercor;bhw267v1 (2016). doi:10.1093/cercor/bhw267
Synaptic dysfunctions and altered neuronal activity play major role in the pathophysiology of Alzheimer's disease (AD), with underlying mechanisms largely unknown. We report that in the prefrontal cortex of amyloid precursor protein-presenilin 1 and